Genetic Variation Within the HLA-DRA1 Gene Modulates Susceptibility to Type 1 Diabetes in HLA-DR3 Homozygotes
Type 1 diabetes (T1D) involves the interaction of multiple gene variants, environmental factors, and immunoregulatory dysfunction. Major T1D genetic risk loci encode HLA-DR and -DQ. Genetic heterogeneity and linkage disequilibrium in the highly polymorphic HLA region confound attempts to identify ad...
Gespeichert in:
| Veröffentlicht in: | Diabetes (New York, N.Y.) Jg. 68; H. 7; S. 1523 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.07.2019
|
| Schlagworte: | |
| ISSN: | 1939-327X, 1939-327X |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Type 1 diabetes (T1D) involves the interaction of multiple gene variants, environmental factors, and immunoregulatory dysfunction. Major T1D genetic risk loci encode HLA-DR and -DQ. Genetic heterogeneity and linkage disequilibrium in the highly polymorphic HLA region confound attempts to identify additional T1D susceptibility loci. To minimize HLA heterogeneity, T1D patients (
= 365) and control subjects (
= 668) homozygous for the HLA-DR3 high-risk haplotype were selected from multiple large T1D studies and examined to identify new T1D susceptibility loci using molecular inversion probe sequencing technology. We report that risk for T1D in HLA-DR3 homozygotes is increased significantly by a previously unreported haplotype of three single nucleotide polymorphisms (SNPs) within the first intron of
The homozygous risk haplotype has an odds ratio of 4.65 relative to the protective homozygous haplotype in our sample. Individually, these SNPs reportedly function as "expression quantitative trait loci," modulating
and -
expression. From our analysis of available data, we conclude that the tri-SNP haplotype within
may modulate class II expression, suggesting that increased T1D risk could be attributable to regulated expression of class II genes. These findings could help clarify the role of HLA in T1D susceptibility and improve diabetes risk assessment, particularly in high-risk HLA-DR3 homozygous individuals. |
|---|---|
| AbstractList | Type 1 diabetes (T1D) involves the interaction of multiple gene variants, environmental factors, and immunoregulatory dysfunction. Major T1D genetic risk loci encode HLA-DR and -DQ. Genetic heterogeneity and linkage disequilibrium in the highly polymorphic HLA region confound attempts to identify additional T1D susceptibility loci. To minimize HLA heterogeneity, T1D patients (
= 365) and control subjects (
= 668) homozygous for the HLA-DR3 high-risk haplotype were selected from multiple large T1D studies and examined to identify new T1D susceptibility loci using molecular inversion probe sequencing technology. We report that risk for T1D in HLA-DR3 homozygotes is increased significantly by a previously unreported haplotype of three single nucleotide polymorphisms (SNPs) within the first intron of
The homozygous risk haplotype has an odds ratio of 4.65 relative to the protective homozygous haplotype in our sample. Individually, these SNPs reportedly function as "expression quantitative trait loci," modulating
and -
expression. From our analysis of available data, we conclude that the tri-SNP haplotype within
may modulate class II expression, suggesting that increased T1D risk could be attributable to regulated expression of class II genes. These findings could help clarify the role of HLA in T1D susceptibility and improve diabetes risk assessment, particularly in high-risk HLA-DR3 homozygous individuals. Type 1 diabetes (T1D) involves the interaction of multiple gene variants, environmental factors, and immunoregulatory dysfunction. Major T1D genetic risk loci encode HLA-DR and -DQ. Genetic heterogeneity and linkage disequilibrium in the highly polymorphic HLA region confound attempts to identify additional T1D susceptibility loci. To minimize HLA heterogeneity, T1D patients (N = 365) and control subjects (N = 668) homozygous for the HLA-DR3 high-risk haplotype were selected from multiple large T1D studies and examined to identify new T1D susceptibility loci using molecular inversion probe sequencing technology. We report that risk for T1D in HLA-DR3 homozygotes is increased significantly by a previously unreported haplotype of three single nucleotide polymorphisms (SNPs) within the first intron of HLA-DRA1. The homozygous risk haplotype has an odds ratio of 4.65 relative to the protective homozygous haplotype in our sample. Individually, these SNPs reportedly function as "expression quantitative trait loci," modulating HLA-DR and -DQ expression. From our analysis of available data, we conclude that the tri-SNP haplotype within HLA-DRA1 may modulate class II expression, suggesting that increased T1D risk could be attributable to regulated expression of class II genes. These findings could help clarify the role of HLA in T1D susceptibility and improve diabetes risk assessment, particularly in high-risk HLA-DR3 homozygous individuals.Type 1 diabetes (T1D) involves the interaction of multiple gene variants, environmental factors, and immunoregulatory dysfunction. Major T1D genetic risk loci encode HLA-DR and -DQ. Genetic heterogeneity and linkage disequilibrium in the highly polymorphic HLA region confound attempts to identify additional T1D susceptibility loci. To minimize HLA heterogeneity, T1D patients (N = 365) and control subjects (N = 668) homozygous for the HLA-DR3 high-risk haplotype were selected from multiple large T1D studies and examined to identify new T1D susceptibility loci using molecular inversion probe sequencing technology. We report that risk for T1D in HLA-DR3 homozygotes is increased significantly by a previously unreported haplotype of three single nucleotide polymorphisms (SNPs) within the first intron of HLA-DRA1. The homozygous risk haplotype has an odds ratio of 4.65 relative to the protective homozygous haplotype in our sample. Individually, these SNPs reportedly function as "expression quantitative trait loci," modulating HLA-DR and -DQ expression. From our analysis of available data, we conclude that the tri-SNP haplotype within HLA-DRA1 may modulate class II expression, suggesting that increased T1D risk could be attributable to regulated expression of class II genes. These findings could help clarify the role of HLA in T1D susceptibility and improve diabetes risk assessment, particularly in high-risk HLA-DR3 homozygous individuals. |
| Author | Noble, Janelle A Blankenhorn, Elizabeth P Bearoff, Frank Bailey, Jeffrey A Marsh, Patrick Aydemir, Özkan Lernmark, Åke Andersson Svärd, Agnes Mordes, John P |
| Author_xml | – sequence: 1 givenname: Özkan surname: Aydemir fullname: Aydemir, Özkan organization: Division of Transfusion Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA – sequence: 2 givenname: Janelle A surname: Noble fullname: Noble, Janelle A organization: Children's Hospital Oakland Research Institute, Oakland, CA – sequence: 3 givenname: Jeffrey A surname: Bailey fullname: Bailey, Jeffrey A organization: Division of Transfusion Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA – sequence: 4 givenname: Åke surname: Lernmark fullname: Lernmark, Åke organization: Department of Clinical Sciences, Lund University/CRC, Skåne University Hospital, Malmö, Sweden – sequence: 5 givenname: Patrick surname: Marsh fullname: Marsh, Patrick organization: Division of Transfusion Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA – sequence: 6 givenname: Agnes surname: Andersson Svärd fullname: Andersson Svärd, Agnes organization: Department of Clinical Sciences, Lund University/CRC, Skåne University Hospital, Malmö, Sweden – sequence: 7 givenname: Frank surname: Bearoff fullname: Bearoff, Frank organization: Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA – sequence: 8 givenname: Elizabeth P surname: Blankenhorn fullname: Blankenhorn, Elizabeth P organization: Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA – sequence: 9 givenname: John P orcidid: 0000-0003-2414-380X surname: Mordes fullname: Mordes, John P email: john.mordes@umassmed.edu organization: Division of Endocrinology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA john.mordes@umassmed.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30962219$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE1PwzAMhiM0xD7gwB9AOXIp5KPJmuO0wYY0hATj41aljceC2qY06aH8ejptSMiS_cp6_Mr2GA0qVwFCl5TcMM6ntyajSUQpS07QiCquIs6mH4N_eojG3n8RQmQfZ2jIiZKMUTVC5RIqCDbHb7qxOlhX4XcbdrbCYQd4tZ5Fi-cZxXsKPzrTFjqAxy-tz6EONrOFDR0ODm-6GjDFC6sz2BO9wWGY45Ur3U_36fr2OTrd6sLDxbFO0Ov93Wa-itZPy4f5bB3lUsYh2hKhgRBKY04BEmEUE9wIzuNYTZXRGWeZlJwYoTIhOFMA25hJnkuaG0MTNkHXB9-6cd8t-JCWtt-4KHQFrvUpY6S_P6F9mqCrI9pmJZi0bmypmy79exH7BZUSZvE |
| CitedBy_id | crossref_primary_10_1016_j_humimm_2021_07_010 crossref_primary_10_1186_s12887_024_04983_w crossref_primary_10_1186_s13098_025_01928_w crossref_primary_10_1016_j_diabres_2025_112359 crossref_primary_10_1155_2022_9554658 crossref_primary_10_3390_jcm14030916 crossref_primary_10_1097_MD_0000000000029781 crossref_primary_10_1016_j_genrep_2025_102183 crossref_primary_10_2337_db20_0374 crossref_primary_10_1111_jdi_13322 crossref_primary_10_2337_dbi18_0034 crossref_primary_10_3389_fimmu_2024_1457213 crossref_primary_10_1038_s41574_024_01045_0 crossref_primary_10_1038_s41598_023_33657_3 |
| ContentType | Journal Article |
| Contributor | Persson, Martina Marcus, Claude Ludvigsson, Johnny Forsander, Gun Elding Larsson, Helena Ivarsson, Sten-Anders Carlsson, Annelie |
| Contributor_xml | – sequence: 1 givenname: Martina surname: Persson fullname: Persson, Martina – sequence: 2 givenname: Helena surname: Elding Larsson fullname: Elding Larsson, Helena – sequence: 3 givenname: Gun surname: Forsander fullname: Forsander, Gun – sequence: 4 givenname: Sten-Anders surname: Ivarsson fullname: Ivarsson, Sten-Anders – sequence: 5 givenname: Johnny surname: Ludvigsson fullname: Ludvigsson, Johnny – sequence: 6 givenname: Claude surname: Marcus fullname: Marcus, Claude – sequence: 7 givenname: Annelie surname: Carlsson fullname: Carlsson, Annelie |
| Copyright | 2019 by the American Diabetes Association. |
| Copyright_xml | – notice: 2019 by the American Diabetes Association. |
| CorporateAuthor | Better Diabetes Diagnosis (BDD) Study Group |
| CorporateAuthor_xml | – name: Better Diabetes Diagnosis (BDD) Study Group |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.2337/db18-1128 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1939-327X |
| ExternalDocumentID | 30962219 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: U01 DK062418 |
| GroupedDBID | --- .55 .GJ .XZ 08P 0R~ 18M 1CY 29F 2WC 354 3V. 4.4 53G 5GY 5RE 5RS 5VS 6PF 7RV 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8GL 8R4 8R5 AAKAS AAQQT AAWTL AAYEP AAYJJ AAYOK ABOCM ABUWG ACGFO ACGOD ACPRK ADBBV ADZCM AEGXH AENEX AERZD AFFNX AFHIN AFKRA AHMBA AI. AIAGR AIZAD ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBNVY BCR BCU BEC BENPR BES BHPHI BKEYQ BKNYI BLC BPHCQ BTFSW BVXVI C1A CCPQU CGR CS3 CUY CVF DIK DU5 DWQXO E3Z EBS ECM EDB EIF EJD EMOBN EX3 F5P FRP FYUFA GICCO GNUQQ GUQSH GX1 H13 HCIFZ HMCUK HZ~ H~9 IAG IAO IEA IHR INH INR IOF IPO ITC J5H K-O K2M K9- KQ8 L7B LK8 M0R M1P M2O M2P M2Q M5~ M7P MVM N4W NAPCQ NPM O5R O5S O9- OB3 OHH OK1 OVD P2P PCD PEA PKN PQQKQ PROAC PSQYO Q2X RHF RHI RPM S0X SJFOW SJN SV3 TDI TEORI TR2 UKHRP VH1 VVN W8F WH7 WOQ WOW X7M XOL YFH YHG YOC YQJ ZGI ZXP ZY1 ~KM 7X8 AAFWJ |
| ID | FETCH-LOGICAL-c664t-f05ae0011431ee85d9253d53344979dab32b6630d59b55329eef4263c61cdd182 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 18 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000473801400015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1939-327X |
| IngestDate | Thu Oct 02 11:42:03 EDT 2025 Wed Feb 19 02:30:59 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | 2019 by the American Diabetes Association. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c664t-f05ae0011431ee85d9253d53344979dab32b6630d59b55329eef4263c61cdd182 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-2414-380X |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/6609989 |
| PMID | 30962219 |
| PQID | 2206228162 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2206228162 pubmed_primary_30962219 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-07-01 |
| PublicationDateYYYYMMDD | 2019-07-01 |
| PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Diabetes (New York, N.Y.) |
| PublicationTitleAlternate | Diabetes |
| PublicationYear | 2019 |
| SSID | ssj0006060 |
| Score | 2.4102995 |
| Snippet | Type 1 diabetes (T1D) involves the interaction of multiple gene variants, environmental factors, and immunoregulatory dysfunction. Major T1D genetic risk loci... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1523 |
| SubjectTerms | Alleles Case-Control Studies Diabetes Mellitus, Type 1 - genetics Female Gene Frequency Genetic Predisposition to Disease Genetic Variation Genotype HLA-DR alpha-Chains - genetics HLA-DR3 Antigen - genetics Homozygote Humans Introns Male Polymorphism, Single Nucleotide |
| Title | Genetic Variation Within the HLA-DRA1 Gene Modulates Susceptibility to Type 1 Diabetes in HLA-DR3 Homozygotes |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30962219 https://www.proquest.com/docview/2206228162 |
| Volume | 68 |
| WOSCitedRecordID | wos000473801400015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELWAIsSFfSmbjMTVamJn8wlVQNUDrSrW3KJ4CfTQpJAUqXw9YydVT0hIXHJI7CiyJ-P3POM3CF1lqZAu2C2BtT4jXqAdAi0jImQglQZ8y0Rki02Ew2EUx3zUbLiVTVrlwidaR60KafbIO5Q6AaWRG9Dr6QcxVaNMdLUpobGKWgygjLHqMF6qhQM4d-qoMieMhnGtLEQZCztKuMCeXBr9jiztCtPb_u-37aCtBlvibm0Mu2hF53toY9BEz_fRxGhMwzP8AgTZzgh-HVfv4xwDCsT9-y65fei62LTCg0KZwl66xI-z0qa-2CzaOa4KbLgrdnGTTFNieEHdmeF-MSm-528F3D5Az727p5s-acotEBkEXkUyx0-1PVzLXK0jX3HqM2WO6no85CoVjArAJ47yufB9RrnWmZF7l4ErlQKecojW8iLXxwgbERgvTaXkvvJCxoXWwvgWCVA-1YHfRpeLgUzAnE2MIs11MSuT5VC20VE9G8m01t1IGNAtCh725A-9T9EmQBteJ9aeoVYGP7M-R-vyqxqXnxfWTuA6HA1-AKWDxmE |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+Variation+Within+the+HLA-DRA1+Gene+Modulates+Susceptibility+to+Type+1+Diabetes+in+HLA-DR3+Homozygotes&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Aydemir%2C+%C3%96zkan&rft.au=Noble%2C+Janelle+A&rft.au=Bailey%2C+Jeffrey+A&rft.au=Lernmark%2C+%C3%85ke&rft.date=2019-07-01&rft.issn=1939-327X&rft.eissn=1939-327X&rft.volume=68&rft.issue=7&rft.spage=1523&rft_id=info:doi/10.2337%2Fdb18-1128&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1939-327X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1939-327X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1939-327X&client=summon |